These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8878616)

  • 1. In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp.
    Wardle HM; Law D; Denning DW
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2229-31. PubMed ID: 8878616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184.
    Fung-Tomc JC; Minassian B; Huczko E; Kolek B; Bonner DP; Kessler RE
    Antimicrob Agents Chemother; 1995 Feb; 39(2):295-300. PubMed ID: 7726485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus, and Blastomyces species.
    Karlowsky JA; Zhanel GG; Balko TV; Zelenitsky SA; Kabani AM; Hoban DJ
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):179-82. PubMed ID: 9327245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; Alonso R; del Valle O; Hernández-Molina JM; McNicholas P; Loebenberg D; Santos P
    J Antimicrob Chemother; 2005 Mar; 55(3):317-9. PubMed ID: 15705637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
    Claudino AL; Peixoto RF; Melhem MS; Szeszs MW; Lyon JP; Chavasco JK; Franco MC
    Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
    Cuenca-Estrella M; Mellado E; Díaz-Guerra TM; Monzón A; Rodríguez-Tudela JL
    J Antimicrob Chemother; 2000 Sep; 46(3):475-7. PubMed ID: 10980178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of pradimicin BMS-181184 against Aspergillus spp.
    Oakley KL; Moore CB; Denning DW
    Int J Antimicrob Agents; 1999 Aug; 12(3):267-9. PubMed ID: 10461847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
    Arikan S; Sancak B; Hascelik G
    Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
    Di Bonaventura G; Spedicato I; Picciani C; D'Antonio D; Piccolomini R
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4453-6. PubMed ID: 15504881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of fluconazole and amphotericin B against Candida inconspicua clinical isolates as determined by the time-kill method.
    Szabó Z; Sóczó G; Miszti C; Hermann P; Rozgonyi F
    Acta Microbiol Immunol Hung; 2008 Mar; 55(1):53-61. PubMed ID: 18507151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
    Ernst EJ; Yodoi K; Roling EE; Klepser ME
    Antimicrob Agents Chemother; 2002 Feb; 46(2):578-81. PubMed ID: 11796383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pradimicin therapy of disseminated Candida tropicalis infection in the mouse.
    Restrepo MI; Najvar LK; Fothergill AW; Graybill JR
    Med Mycol; 1998 Jun; 36(3):181-4. PubMed ID: 9776832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
    Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
    Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
    Uzun O; Arikan S; Kocagöz S; Sancak B; Unal S
    Diagn Microbiol Infect Dis; 2000 Oct; 38(2):101-7. PubMed ID: 11035241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility testing of Candida albicans by flow cytometry.
    Gökahmetoglu S; Nedret Koç A; Patiroglu T
    Mycoses; 2003 Sep; 46(8):307-11. PubMed ID: 12950899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.